| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -18,714 |
| Depreciation and amortization | 10,549 |
| Provision for credit loss reserve | 220 |
| Stock-based compensation | 27,351 |
| Non-cash interest expense | 5,517 |
| (gain) loss on debt extinguishment | 327 |
| Deferred tax provision (benefit) | 241 |
| Goodwill impairment | 0 |
| Unrealized foreign currency transaction gain | 2,561 |
| Other, net | 2,363 |
| Accounts receivable | 1,398 |
| Prepaid expenses and other assets | -32,137 |
| Deferred costs | -3,884 |
| Accounts payable | -3,150 |
| Accrued expenses and other liabilities | -18,237 |
| Deferred revenue | 23,298 |
| Net cash provided by operating activities | 61,173 |
| Capital expenditures | 14,356 |
| Purchases of marketable securities | 0 |
| Sale and maturities of marketable securities | 5,512 |
| Other investing activities | 1,710 |
| Net cash (used in) provided by investing activities | -10,554 |
| Principal payments of short-term debt | 87,089 |
| Proceeds from revolving credit facility | 0 |
| Payments of revolver credit facility | 0 |
| Proceeds from long-term debt, net of discount | 0 |
| Payments for long-term debt issuance costs | 0 |
| Principal payments of long-term debt | 0 |
| Common stock repurchases for tax withholdings for net settlement of equity awards | 2,380 |
| Principal payment of lease liabilities arising from a finance lease | 411 |
| Proceeds from the issuance of common stock | 2,879 |
| Net cash (used in) provided by financing activities | -87,001 |
| Effect of foreign currency exchange rates on cash and cash equivalents | -1,086 |
| Net change in cash and cash equivalents | -37,468 |
| Cash and cash equivalents at beginning of period | 121,485 |
| Cash and cash equivalents at end of period | 84,017 |
Cerence Inc. (CRNC)
Cerence Inc. (CRNC)